TrialInternational journal of dermatology2026

Improvement in Patient-Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO-2b/3.

Ernest H Law et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.